Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 266-564-7 | CAS number: 67075-37-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Oral: LD50 (m/f) > 5000 mg/kg bw, rat, similar to OECD TG 401, no GLP
Inhalation: Read-across, LC50 (m/f) > 5.2 mg/L air, rat, according to OECD TG 403, no GLP
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- The study was conducted according to an internal method which in principle is comparable to the OECD Guideline 401. A test group consisting of 5 animals/sex was treated by single gavage application with an aqueous solution of the test substance. The animals were observed for mortality and for clinical symptoms of toxicity. At the end of the observation period of 14 days, the surviving animals were sacrificed for the purpose of necropsy; animals that died during the observations period also were subjected to necropsy.
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Specific details on test material used for the study:
- - Purity: approx. 100%
- Physical state: solid - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Gassner (breeder)
- Weight at study initiation: mean weight: males: 230 g, females: 180 g
- Diet (e.g. ad libitum): HERILAN MRH-Haltung, Alleinfutter für die Haltung von Mäusen, Ratten und Hamstern, Heinrich EGGERSMANN KG, Rinteln - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Remarks:
- 0.5 % in water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 50 % in 0.5 % aqueous CMC
- Amount of vehicle (if gavage): 10 ml/kg
MAXIMUM DOSE VOLUME APPLIED: males: 2.3 ml; females 1.8 ml (10 ml/kg bw). - Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: daily (except on weekends)
- Frequency of weighing: before treatment and on days 2, 7 and 13
- Necropsy of survivors performed: yes - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- None of the animals died during the exposure period.
- Clinical signs:
- other: No abnormal observations, animals were in good general health throughout the study.
- Body weight:
- other body weight observations
- Remarks:
- Normal weight gain
- Gross pathology:
- No abnormal observations.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- According to the EU and GHS classification criteria, no classification is warranted as to acute oral toxicity for the test substance.
- Executive summary:
The study was conducted according to an internal method which in principle is comparable to the OECD Guideline 401. A test group consisting of 5 animals/sex was treated by single gavage application with an aqueous solution of the test substance (5000 mg/kg bw, 50 % in 0.5 % aqueous carboxymethyl cellulose). The animals were observed for mortality and for clinical symptoms of toxicity. At the end of the observation period of 14 days, the surviving animals were sacrificed for the purpose of necropsy. Animals that died during the observations period also were subjected to necropsy. No mortality, no abnormal clinical signs an no abnormal findings at necropsy were noted.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Justification for type of information:
- see attached justification
- Reason / purpose for cross-reference:
- read-across source
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.2 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- not determinable
- Remarks:
- (no mortality observed)
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04 Oct 2005 - 07 Nov 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1300 (Acute inhalation toxicity)
- Qualifier:
- according to guideline
- Guideline:
- other: EU Guideline 92/69/EEC and 93/21/EEC
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
- Specific details on test material used for the study:
- - Physical state: Solid, black powder
- Analytical purity: > 99%
- Storage condition of test material: Room temperature
- Homogeneous - Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Laboratory Animal Services; Wölfersraße 4, 4414 Füllinsdorf, Switzerland
- Age at study initiation: 9 weeks for males and approx. 11 weeks for females.
- Weight at study initiation: males: 260,5 g (mean); females: 205,3 g (mean)
- Housing: singly in cages type DK III (Becker, Germany) without bedding
- Diet: KLIBA mouse / rat laboratory diet 10 mm pellets "GLP", Provimi Kliba SA, Kaiseraugst, Basel Switzerland, ad libitum
- Water: drinking water ad libitum
- Acclimation period: at least 1 week in which they were adapted to the surroundings
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24°C
- Humidity (%): 30 - 70%
- Photoperiod (hrs dark / hrs light): dark cycle of 12 hours - Route of administration:
- other: dust aerosol
- Type of inhalation exposure:
- nose/head only
- Vehicle:
- other: 2% (w/w) of Aerosil 200
- Mass median aerodynamic diameter (MMAD):
- >= 3 - <= 3.1 µm
- Geometric standard deviation (GSD):
- >= 3.1 - <= 3.3
- Details on inhalation exposure:
- GENERATION OF THE INHALATION ATMOSPHERE
- The test substance was stirred in its container before a sample for dust generation was taken. The test substance was desagglomerated in a mixer under addition of 2% (w/w) of Aerosil 200 before introduction into the dust generator, in order to improve dust aerosol formation. The dust was produced inside the inhalation system with a dosing-wheel dust generator and compressed air.
EXPOSURE
- The exposure system was located inside an exhaust cabin in an air-conditioned laboratory. A supply air flow (compressed air) of 1.5 m³/h was used for the exposure. The exhaust airflow was set to 1.35 m³/h. An air change of about 27 times per hour can be calculated by dividing the supply air flow by the volume of the inhalation system.
- The lower amount of exhaust air, which was adjusted by means of a separate exhaust air system, achieved a positive pressure inside the exposure system . This ensured that the mixture of test substance and air was not diluted with laboratory air in the breathing zones of the animals. The animals were exposed to the inhalation atmosphere for 4 hours plus equilibration time of the inhalation systems (t99 about 10 min).
Measurement of operation conditions
- The flows of supply and exhaust air were adjusted and continuously measured with flowmeters. They were recorded four times in about 1-hour intervals. The temperature in the inhalation system was measured continuously with a digital thermometer and recorded four times in about 1-hour intervals. The humidity in the inhalation system was measured with a dielectric probe four times in about 1-hour intervals.
- No surveillance of the oxygen content in the inhalation system was performed. The air change was judged to be sufficient to prevent oxygen depletion by the breathing of the animals, and the concentration of the test substance used could not have a substantial influence on oxygen partial pressure.
Gravimetric determination of the inhalation atmosphere concentration:
Equipment: balance Mettler AT 250. Preweighed filters were placed into the filtration equipment. By means of the vacuum pump metered volumes of the dust were drawn through the filter. For each sample the dust aerosol concentration in mg/I was calculated from the difference between the preweight of the filter and the weight of the filter after sampling, with reference to the sample volume of the inhalation atmospheres. Mean and standard deviation were calculated for the concentration from the results of the individual measurements. The mean concentration was corrected for the amount of additive used.
Particle size analysis:
Definitions
• EACD 50% (effective aerodynamic cutoff diameter 50%) defines the separation characteristic of each impactor stage. 50% of particles with the EACD given are deposited in the pertinent impactor stage; the remainder has reached one of the following stages.
• MMAD (mass median aerodynamic diameter) is the calculated aerodynamic diameter which divides the size distribution in half when measured by mass.
• Geometrical standard deviation (GSD) is the ratio of the estimated 84 percentile to the 50 percentile and indicates the slope of the cumulative particle size distribution curve.
• Inspirable aerosol
Inspirable aerosols can enter the respiratory system. Aerosols with MMAD <100 Nm are considered inspirable (MAK Commission of the DFG (German Research Society, MAK list 1997).
• Respirable aerosol
Respirable aerosols can enter the alveolar region of the lung. Aerosols with MMAD < 4 Nm are considered respirable (MAK Commission of the DFG (German Research Society, MAK list 1997).
Before sampling, the impactor was assembled with preweighed glass-fiber collecting discs, and a backup particle filter. The impactor was connected to the vacuum pump and two samples were taken from the breathing zone of the animals starting not earlier than 30 minutes after the beginning of the exposure. The sample volume was 6 L. After sampling the impactor was taken apart. The collecting discs and the backup particle filter were re-weighed. The amounts of material adsorbed to the walls of the impactor and in the sampling probe (wall losses) were also determined quantitatively. The results from the particle size analysis were not corrected for the additive.
- Exposure conditions:
Supply air (m³/h): 1.5
Exhaust air (m³/h): 1.35
Substance flow (g/h): 36.1
Temperature (°C): 21.8±0.3
Relative humidity (%): 47.7±2.2
- Analytical concentration:
Mean mg/l: 5.2
Standard deviation: 1.0
Nominal concentration mg/l: 24.1
- Particle size analysis:
MMAD (µm): 3.1 and 3.0
Geometrical standard deviation: 3.1 and 3.3 - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- Gravimetric determination
- Duration of exposure:
- 4 h
- Concentrations:
- 5.2 mg/l (nominal concentration: 24.1 mg/l)
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: A check for overt clinical signs of toxicity or mortality as well as a check for the presence of feed and drinking water was made twice a day on workdays and once daily on weekends and public holidays. Detailed clinical observations were recorded for each animal separately several times during exposure and at least once on each workday of the observation period.
- Body weights: The body weight of the animals was determined just prior to exposure (day 0), weekly thereafter and at the end of the observation period.
- Necropsy of survivors performed: yes. At the end of the observation period the animals were sacrificed with C02 and were subjected to gross-pathological examination - Statistics:
- A binomial test was used for statistical evaluation.
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.2 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- not determinable
- Remarks:
- (no mortality observed)
- Mortality:
- No lethality occurred at the tested concentration of 5.2 mg/I during the study period of 14 days.
- Clinical signs:
- other: Accelerated respiration, pulmonary respiration e sounds, squatting posture, piloerection and smeared fur. Findings were observed from hour 0 of exposure until including study day 3.
- Body weight:
- The mean body weights of the animals increased throughout the study period.
- Gross pathology:
- No pathological abnormalities of the organs were observed in all animals at termination of the study.
- Other findings:
- Contaminated fur was noted during necropsy in all animals.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of this study the LC50 for male and female rats after dust inhalation was determined to exceed 5 .2 mg/I.
- Executive summary:
For determination of the acute inhalation toxicity (single 4-hour-exposure) of the test substance as dust, a GLP compliant study in male and female Wistar rats was performed according to OECD-Guideline method 403, as well as EEC and EPA guidelines. A measured concentration of 5 .2 mg/I was tested (Limit test). Cascade impactor measurements resulted in particle size distributions with mass median aerodynamic diameters (MMADs) of 3.0 and 3.1 µm, which are well within the respirable range. No mortality occurred at the tested concentration. Clinical signs of toxicity comprised visually accelerated respiration, pulmonary respiration sounds, squatting posture, piloerection and smeared fur. Findings were observed from hour 0 of exposure until including study day 3. Moreover, contaminated fur was observed in all animals from day 0 onward until termination of the study. The mean body weights of the animals increased throughout the study period. No pathological abnormalities of the organs were observed in all animals at termination of the study. Contaminated fur was noted during necropsy in all animals. Under the conditions of this study the LC50 for male and female rats after dust inhalation was > 5 .2 mg/l.
Referenceopen allclose all
Analytical concentration:
Mean (mg/l) | standard deviation | nominal concentration (mg/l) |
5.2 | 1 | 24.1 |
Particle Size Analysis:
Sample | MMAD (µm) | geometrical standard deviation |
1 | 3.1 | 3.3 |
2 | 3 | 3.1 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating conc.
- Value:
- 5 200 mg/m³ air
- Physical form:
- inhalation: dust
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Oral toxicity
In an oral toxicity study comparable to OECD guideline 401, rats (5/sex/dose) were treated with the test substance at a dose level of 5000 mg/kg bw by single dose (gavage) followed by a 14-day observation period (BASF, 1979). None of the animals died during the exposure period. All animals showed normal body weight gain and no abnormal findings were observed regarding clinical signs and at necropsy. The LD50 was therefore determined to be greater than 5000 mg/kg body weight.
Inhalation toxicity
Regarding inhalation toxicity, the available data is not regarded for assessment, as the design of the inhalation risk test (BASF, 1979), is insufficient for non-volatile substances. To fill this data gap, a read-across to the category member EC 479-300-2 was performed. For determination of the acute inhalation toxicity (single 4-hour-exposure) of the test substance, a GLP compliant study in male and female Wistar rats was performed according to OECD-Guideline method 403, as well as EEC and EPA guidelines. A measured dust concentration of 5.2 mg/L was tested (Limit test). Cascade impactor measurements resulted in particle size distributions with mass median aerodynamic diameters (MMADs) of 3.0 and 3.1 µm, which are well within the respirable range. No mortality occurred at the tested concentration. Clinical signs of toxicity comprised visually accelerated respiration, pulmonary respiration sounds, squatting posture, piloerection and smeared fur. Findings were observed from hour 0 of exposure until including study day 3. Moreover, contaminated fur was observed in all animals from day 0 onward until termination of the study. The mean body weights of the animals increased throughout the study period. No pathological abnormalities of the organs were observed in all animals at termination of the study. Contaminated fur was noted during necropsy in all animals. Under the conditions of this study the LC50 for male and female rats after dust inhalation was > 5 .2 mg/l.
Further toxicological data of category members:
The test article belongs to the "perylene based organic pigments" category (see attached document for details on category members and for read across justification). According to the category approach, missing toxicity endpoints can be addressed with data available for other category members. Regarding acute toxicity, reliable data are available for the test article and for other members of the "Perylene based pigments category". All of these data are taken into account for the evaluation and assessment of the acute toxicity of the test article.
Additional information is available for the oral and the inhalation route:
In several studies performed with other substances from the Perylene category the potential for oral toxicity was found to be very low. None of these studies raised any concerns regarding acute toxicity after oral application and therefore none of the substances requires classification. The LD50 values observed for these compounds were greater than 5000 mg/kg bw in alle studies performed.
To assess the acute inhalation toxicity, other category members were tested in studies according or similar to OECD 403 guideline. In all studies, rats were exposed to analytically verified dust aerosols for a duration of 4 hours. Except for one study with a single case of mortality all animals survived the procedure. The observed clinical signs included accelerated respiration, pulmonary respiration sounds, squatting posture, piloerection, flight behavior and smeared fur. No pathological abnormalities of the organs were observed at termination in all animals in any of the studies. The LC50 was always greater than tested limit dose respectively.
There are also studies concerning the acute dermal toxicity. In the studies similar to OECD testing guideline 402 no signs for s local or systemic toxicity could be found.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. No mortality occurred at the limit dose of 2000 mg/kg bw. As a result, the substance is not considered to be classified for acute oral or inhalation toxicity under Regulation (EC) No. 1272/2008, as amended for the fourteenth time in Regulation (EC) No. 2020/217.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
